Navigation Links
Bone marrow and blood stem cell transplant survival rates equal, when donor is unrelated to patient

Patients who receive a blood stem cell transplant from a donor outside of their family to treat leukemia and other blood diseases are more likely to have graft failure but less likely to experience graft-versus-host disease, a condition caused by the donor cells attacking the recipient's body, if the transplanted blood cells come directly from a donor's bone marrow, rather than from blood stem cells circulating in the donor's bloodstream (PBSCs), according to new research. Although the study showed differences in the type and extent of complications, the results showed no difference in patient survival rates between these two major sources of donated blood cells.

The study, presented in the plenary session of the 53rd annual American Society of Hematology conference in San Diego, was conducted by the Blood and Marrow Transplant Clinical Trials Network (BMT CTN), a collaborative effort of the Center for International Blood and Marrow Transplant Research (CIBMTR) at the Medical College of Wisconsin, the National Marrow Donor Program (NMDP), and the EMMES Corporation, together with 20 core transplant centers/consortia.

The randomized study included 50 transplant centers in the United States and Canada and compared two-year survival rates for 273 patients receiving PBSC with 278 patients receiving bone marrow. The study found that survival was the same using either blood cell source, but the complications following transplant were different depending on which source was used.

PBSCs resulted in better engraftment than bone marrow, but was associated with higher rates of chronic graft-versus-host-disease (GVHD) (53% compared with 40% in bone marrow), and the GVHD was also more extensive. GVHD is a serious and often deadly post-transplant complication that occurs when the newly transplanted donor cells recognize the recipient's own cells as foreign and attack them.

"The study shows that many patients with life-threatening blood cancers can be cured with transplants from unrelated donors but also highlights areas where new strategies are needed to improve outcomes," said Mary Horowitz, M.D., chief scientific director of the CIBMTR at the Medical College, Robert A. Uihlein, Jr. Professor in Hematologic Research, and a co-author of the study.


Contact: Maureen Mack
Medical College of Wisconsin

Related medicine news :

1. Biomarker detects graft-versus-host-disease in cancer patients after bone marrow transplant
2. Bone marrow cells migrate to tumors and can slow their growth
3. New half-match bone marrow transplant procedure yields promising outcomes for cancer patients
4. Bone marrow transplantation may increase cancer resistance in patients
5. Stem cell mobilization therapy found to be safe for bone marrow donors
6. Bone marrow transplant survival more than doubles for young high-risk leukemia patients
7. Gene-modified stem cells help protect bone marrow from toxic side effects of chemotherapy
8. Study reveals origins of a cancer affecting the blood and bone marrow
9. Marrow Donation From Teenage Stranger Saves Mans Life
10. Study identifies drug resistance of CLL in bone marrow and lymph nodes
11. Jefferson study determines bone marrow stromal stem cells may aid in stroke recovery
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... Altec Products, ... Title Sponsorship of Synergy 2015. The annual WennSoft KEY2ACT user conference will take ... and will unite customers, partners, WennSoft team members and sponsors to facilitate the ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... County, Illinois with more than 59,000 emergency department visits per year, today announced ... from T-System, to help improve clinical, operational and financial outcomes. , ...
(Date:10/13/2015)... ... 2015 , ... California Southern University has named Dr. Judith ... Doctor of Nursing Practice from the renowned Johns Hopkins University—comes to CalSouthern with ... McLeod’s long and successful nursing practice included a variety of patient care, education ...
(Date:10/13/2015)... CA (PRWEB) , ... October 13, 2015 , ... According ... Derrick Rose suffered an orbital fracture when a teammate accidentally elbowed him in the ... 2015. Rose's recent eye injury is just one of a series of setbacks, including ...
(Date:10/13/2015)... ... ... With Fall weather approaching and holiday travel season upon us, is giving away ... to win! , How to Enter:, 1. Like on Facebook , 2. ... us on Instagram @thebeautyplace , 4. Share Facebook Contest Image With Friends , ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... Research and Markets ( ) has announced the ... Yeast, Mold, Others), Flavors (Herbs & Spices, Citrus, Berries, ... - Forecasts to 2020" report to their offering. ... --> The global market for kombucha has grown ... value, the market is projected to reach USD 1.8 ...
(Date:10/13/2015)... WuXi PharmaTech (Cayman) Inc. (NYSE:  WX), a ... serving the pharmaceutical, biotechnology, and medical device industries, ... version of OncoWuXi, the first App in the ... and data on the go.  The OncoWuXi App ... to identify relevant tumor models for use in ...
(Date:10/13/2015)... , Oct. 13, 2015  The ... Harvard University today announced the launch of ... Ultivue will introduce imaging reagents providing ... to those of expensive specialized instruments. The ... Harvard,s Office of Technology Development (OTD) ...
Breaking Medicine Technology: